Winton Group LTD Mirati Therapeutics, Inc. Transaction History

Winton Group LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$36.54 - $54.26 $21,193 - $31,470	-580 Reduced 7.43%	7,229 $268,000
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $37,596 - $89,842	911 Added 13.21%	7,809 $353,000
Q3 2022 Nov 10, 2022	SELL	$59.5 - $86.7 $59,559 - $86,786	-1,001 Reduced 12.67%	6,898 $482,000
Q2 2022 Aug 10, 2022	BUY	$39.16 - $88.71 $55,685 - $126,145	1,422 Added 21.95%	7,899 $530,000
Q1 2022 May 11, 2022	BUY	$75.82 - $150.97 $373,186 - $743,074	4,922 Added 316.53%	6,477 $533,000
Q4 2021 Feb 10, 2022	SELL	$132.01 - $190.29 $417,019 - $601,126	-3,159 Reduced 67.01%	1,555 $228,000
Q3 2021 Oct 28, 2021	SELL	$132.13 - $177.45 $55,362 - $74,351	-419 Reduced 8.16%	4,714 $834,000
Q2 2021 Aug 10, 2021	SELL	$144.0 - $179.73 $139,680 - $174,338	-970 Reduced 15.89%	5,133 $829,000
Q1 2021 Jul 21, 2021	SELL	$158.92 - $221.61 $78,347 - $109,253	-493 Reduced 7.47%	6,103 $1.05 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $2.3 Million - $3.42 Million	-14,216 Reduced 68.31%	6,596 $1.45 Million
Q3 2020 Oct 30, 2020	BUY	$113.26 - $167.27 $2.36 Million - $3.48 Million	20,812 New	20,812 $3.46 Million
Q1 2019 May 13, 2019	SELL	$43.65 - $78.95 $318,645 - $576,335	-7,300 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$32.0 - $47.43 $57,184 - $84,757	1,787 Added 32.41%	7,300 $310,000
Q3 2018 Nov 02, 2018	BUY	$47.1 - $62.7 $259,662 - $345,665	5,513 New	5,513 $0

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.